Cardiol Therapeutics (CRDL) Change in Account Payables: 2020-2024
Historic Change in Account Payables for Cardiol Therapeutics (CRDL) over the last 5 years, with Dec 2024 value amounting to -$777,692.
- Cardiol Therapeutics' Change in Account Payables rose 2173.40% to $5.9 million in Q3 2022 from the same period last year, while for Sep 2022 it was $11.9 million, marking a year-over-year change of. This contributed to the annual value of -$777,692 for FY2024, which is 18.83% up from last year.
- Latest data reveals that Cardiol Therapeutics reported Change in Account Payables of -$777,692 as of FY2024, which was up 18.83% from -$958,086 recorded in FY2023.
- Cardiol Therapeutics' 5-year Change in Account Payables high stood at $3.4 million for FY2022, and its period low was -$958,086 during FY2023.
- Over the past 3 years, Cardiol Therapeutics' median Change in Account Payables value was -$777,692 (recorded in 2024), while the average stood at $568,697.
- Its Change in Account Payables has fluctuated over the past 5 years, first soared by 80.24% in 2022, then slumped by 127.84% in 2023.
- Over the past 5 years, Cardiol Therapeutics' Change in Account Payables (Yearly) stood at $1.4 million in 2020, then skyrocketed by 40.08% to $1.9 million in 2021, then surged by 80.24% to $3.4 million in 2022, then slumped by 127.84% to -$958,086 in 2023, then climbed by 18.83% to -$777,692 in 2024.